Global Glycomics Market By Product (Enzymes, Instruments, Kits, and Reagents), Application (Diagnostics, Drug Discovery & Development, Oncology, Immunology, Other Applications), End- User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Glycomics Market
The glycomics market is expected to witness market growth at a rate of 14.25% in the forecast period of 2021 to 2028 and is expected to reach USD 12220.06 million by 2028. Data Bridge Market Research report on glycomics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in demand for various applications is escalating the growth of glycomics market.
Glycomics refers to the complete study of structure and also, the function of the glycans of a given cell or organism. Some of the common applications of the glycomics include diagnostics, drug discovery and immunology among others. High-performance liquid chromatography and Matrix-assisted laser desorption ionization-time of flight mass spectrometry are some of the common technique that are utilized in glycomics.
The rise in the Proteomics sector acts as one of the major factors driving the growth of glycomics market. The increase in investments in research by various government bodies and the rise in the need for advanced analytical methods for studying pathogen and human glycobiology in disease and health accelerate the market growth. The development of novel drugs by pharmaceutical and biotechnology companies and rise in focus on glycomics and proteomics research studies further influence the market. Additionally, research and development, improving healthcare infrastructure and surge in investments by pharmaceutical companies positively affect the glycomics market. Furthermore, increase in demand for biomarker identification and personalized medicine extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the tools is expected to obstruct the market growth. Lack of skilled professionals is projected to challenge the glycomics market in the forecast period of 2021-2028.
This glycomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on glycomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Glycomics Market Scope and Market Size
The glycomics market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the glycomics market is segmented into enzymes, instruments, kits, and reagents. Enzymes are further segmented into glycosidases & neuramidases, glycosyltransferases & sialytransferases and other enzymes. Other enzymes are further sub-segmented into carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases. Instruments are further segmented into mass spectrometry instruments, chromatography instruments, arrays and Other Instruments. Other Instruments are further sub-segmented into electrophoresis instruments, NMR instruments, and HPLC columns. Kits are further segmented into glycan releasing kits, glycan labeling kits, glycan purification kits and other kits. Other kits are further sub-segmented into glycan detection kits, glycan enrichment kits, and glycan sample preparation kits. Carbohydrates are further segmented into oligosaccharides, monosaccharides and other carbohydrates.
- On the basis of application, the glycomics market is segmented into Diagnostics, Drug Discovery & Development, Oncology, Immunology and Other Applications.
- On the basis of end-user, the glycomics market is segmented into Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Contract Research Organizations.
Global Glycomics Market Country Level Analysis
The glycomics market is analyzed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the global glycomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glycomics market because of the presence of key pharmaceutical and biopharmaceutical companies, accessibility to advanced products and presence of well-established healthcare infrastructure within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 because of the evolving pharmaceutical and biopharmaceutical industries and development and production of drugs and biologics in the region.
The country section of the glycomics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The glycomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glycomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glycomics market. The data is available for historic period 2010-2019.
Competitive Landscape and Glycomics Market Share Analysis
The glycomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to glycomics market.
The major players covered in the glycomics market report are Merck KGaA, Shimadzu Corporation, Bruker, ProZyme, WATERS, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., New England Biolabs, Asparia Glycomics, Vector Laboratories, Beth Israel Deaconess Medical Center, glyconet Berlin Brandenburg eV, University of Georgia, GlySign, Canadian Glycomics Network, GlycoDisplay., RayBiotech, Inc., Glycodiag, LABORATORIOS FARMACEUTICOS ROVI SA, Glyco Expression Technologies, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-